DiaMedica discusses Q4 2024 earnings and future plans

DiaMedica Therapeutics Inc. held its Q4 2024 earnings call on March 18, 2025. The call featured President and CEO Rick Pauls, Chief Financial Officer Scott Kellen, and Chief Medical Officer Dr. Lorianne Masuoka. During the call, DiaMedica discussed its performance for the year and provided insights on upcoming projects. The company highlighted its commitment to innovation in the healthcare sector. Before detailed discussions, the operator reminded attendees that the call may contain forward-looking statements. These statements involve risks and uncertainties, which could lead to actual results being different from the predictions made. More details on these risks can be found in the company's recent press release and annual report. The company emphasized that comments made during the call are valid only for that day. They will not be responsible for updates on these statements in the future. After the remarks, the call will open for questions from analysts and investors.